Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Ishibazawa A, Nagaoka T, Takahashi A, et al. This paper describes the development of split-spectrum amplitude-decorrelation angiography (SSADA) to improve the signal-to-noise ratio of flow detection in OCT angiography. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Safety of fluorescein angiography during pregnancy: reply. An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report. Fluorescein angiography complication survey. Yannuzzi LA, Rohrer KT, Tindel LJ, et al. Frequency of adverse systemic reactions occurring after fluorescein angiography – results of a prospective study. Kwiterovitch KA, Maguire MG, Murphy RP, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Wilkinson CP, Ferris 3rd FL, Klein RE, Global Diabetic Retinopathy Project Group, et al. A modification of the Airlie House classification of diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. Diabetes - a common, growing, serious, costly, and potentially preventable public health problem. Venkat Narayan KM, Gregg E, Fagot-Campagna A, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus. Saaddine J, Honeycutt AA, Venkat Narayan KM, et al. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Undiagnosed NIDDM: clinical and public health issues. Global prevalance and major risk factors of diabetic retinopathy. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. The Wisconsin epidemiologic study of diabetic retinopathy. Papers of particular interest, published recently, have been highlighted as: In patients who cannot safely undergo FA, OCTA may serve as an alternative form of angiography that can be safely and more frequently performed for the management of diabetic retinopathy. OCTA requires patients to maintain good fixation to obtain high-resolution images which can be a challenge for those with severe macular disease. Despite these advantages, imaging with OCTA can only provide a limited view of the peripheral retina and is unable to demonstrate leakage, staining, or pooling. OCTA capillary perfusion density maps and average perfusion density values provide an easy way to grade progressive vascular change. OCTA offers several advantages over fluorescein angiography (FA) in that it is faster, safer, and non-invasive, allows better visualization of retinal vessels in both the superficial and deep capillary layers, and can provide quantitative measurements of areas of non-perfusion of the macula and nerve. Using OCTA, the vascular changes of diabetic retinopathy including microaneurysms, retinal non-perfusion, intraretinal microvascular abnormalities, and neovascularization can be clearly visualized. Optical coherence tomography angiography (OCTA) is a novel angiography technique that has the capability to advance our understanding of diabetic eye disease by providing high-resolution images of retinal and choroidal microvasculature blood flow and structure. Diabetic retinopathy is a progressive microvascular disease that leads to increased vessel permeability, retinal ischemia, and retinal neovascularization.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |